2017 Buyer’s Guide

This Buyer’s Guide offers a searchable, comprehensive listing of the FDA-approved interventional devices available in the United States.

 
 

News

 

Kawasumi’s Najuta Thoracic Stent Graft Receives CE Mark Approval for TEVAR

October 17, 2017 -- Kawasumi Laboratories, Inc. announced European CE Mark approval in July for the Najuta thoracic stent graft system, which is indicated for thoracic endovas…

First Patient Enrolled in Vivasure’s Frontier IV Clinical Trial

October 13, 2017 -- Vivasure Medical announced that the first patient was enrolled in the Frontier IV clinical study, a nonrandomized, multicenter trial designed to expand the…

MAJESTIC 3-Year Data Published for Boston Scientific's Eluvia DES

October 11, 2017 -- The 3-year results of the MAJESTIC first-in-human study of the Eluvia paclitaxel-eluting vascular stent system (Boston Scientific) for treating femoropopli…

CryoLife to Acquire Jotec

October 10, 2017 -- Jotec GmbH, an endovascular medical device company based in Hechingen, Germany, and CryoLife, which is based in Kennesaw, Georgia, announced an agreement u…

Financing Will Support Clinical Development and Commercialization of Shockwave Medical's Lithoplasty Technology

October 10, 2017 -- Shockwave Medical, Inc. announced new financing that will be used to expand commercialization and advance clinical development of the company’s perip…

Registry Evaluates 1-Day Discharge for Elderly Patients After Lower Extremity Endovascular Revascularization

October 10, 2017 -- Findings from the SENIOR-ER registry were recently published by Adam Janas, MD, et al online ahead of print in Catheterization and Cardiovascular Intervent…

Click here for more News coverage

Current Supplement

Sponsored by BOSTON SCIENTIFIC CORPORATION

Setting Standards. Exceeding Expectations.

Interventional Oncology Tools & Techniques

Current European Supplement

Sponsored by BOSTON SCIENTIFIC CORPORATION

Drug-Eluting Technologies

Choosing the Best Option Through Data-Informed Decision Making.

Featured Center

 

Embolization

advertisement

 
Vascular Market Price  Change
Abbott Laboratories $54.97  0.61%
AstraZeneca PLC $34.58  -0.22%
Avinger $0.34  -1.34%
Boston Scientific Corporation $29.23  0.22%
BTG plc $724.00  2.40%
Cardinal Health $64.73  0.15%
Cardiovascular Systems Inc. $27.54  1.55%
CR Bard Inc. $323.58  0.09%
Edwards Lifesciences Corp. $109.67  1.06%
Vascular Market Price  Change
Endologix Inc. $5.01  -1.09%
Johnson and Johnson $138.95  2.08%
Lombard Medical, Inc. $0.43  -2.69%
Medtronic, Inc. $77.93  0.26%
Merit Medical Systems, Inc. $42.35  -0.12%
Penumbra, Inc. $93.20  0.70%
Philips $40.26  -0.69%
Stryker $148.09  0.54%
Teleflex Inc. $239.36  0.14%
The Medicines Company $34.75  -0.37%

@EVToday

Stay current: Follow Endovascular Today on Twitter @EVToday

Contact Info

For advertising rates and opportunities, contact:
Craig McChesney
484-581-1816
cmcchesney@bmctoday.com

Stephen Hoerst
484-581-1817
shoerst@bmctoday.com

Charles Philip
484-581-1873
cphillip@bmctoday.com

About Endovascular Today

Endovascular Today is a publication dedicated to bringing you comprehensive coverage of all the latest technology, techniques, and developments in the endovascular field. Our Editorial Advisory Board is composed of the top endovascular specialists, including interventional cardiologists, interventional radiologists, vascular surgeons, neurologists, and vascular medicine practitioners, and our publication is read by an audience of more than 22,000 members of the endovascular community.